Publications
Selected Publications:
Wu, C. Y., Yu, K., Arnold, S. E., Das, S., & Dodge, H. H. (2024). Who benefited most from the Internet-based Conversational Engagement RCT (I-CONECT)? Application of the personalized medicine approach to a behavioral intervention study. The Journal of Prevention of Alzheimer's Disease. Advance online publication. https://doi.org/10.14283/jpad.2024.1
Trombetta, B. A., Wu, C. Y., Kuo, E., de Geus, M. B., Dodge, H. H., Carlyle, B. C., Kivisakk, P., & Arnold, S. E. (2024). Cerebrospinal fluid biomarker profiling of diverse pathophysiological domains in Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 10(1), e12440. https://doi.org/10.1002/trc2.12440
Schwab, N., Wu, C.-Y., Galler, J., DeRamus, T., Ford, A., Gerber, J., Kitchen, R., Rashid, B., Riley, M., Sather, L., Wang, X., Young, C., Yang, L., Dodge, H. H., & Arnold, S. E. (2023). Feasibility of common, enjoyable game play for assessing daily cognitive functioning in older adults. Frontiers in Neurology, 14, 1258216. https://doi.org/10.3389/fneur.2023.1258216
Al Ali, J., Vaine, C. A., Shah, S., Campion, L., Hakoum, A., Supnet, M. L., Acuña, P., Aldykiewicz, G., Multhaupt-Buell, T., Ganza, N., Lagarde, J., De Guzman, J. K., Go, C., Currall, B., Trombetta, B., Webb, P. K., Talkowski, M., Arnold, S. E., Cheah, P. S., Ito, N., … Breakefield, X. O. (2021). TAF1 Transcripts and Neurofilament Light Chain as Biomarkers for X-linked Dystonia-Parkinsonism. Movement disorders: official journal of the Movement Disorder Society, 36(1), 206–215.
Schwab, N. A., DesRuisseaux, L. A., Weinberg, M. S., & Arnold, S. E. (2020). Saving cognitive outcome data in Alzheimer's disease clinical trials during the COVID-19 pandemic: Commentary on the virtual administration of the ADAS-Cog. Alzheimer's & Dementia (New York, N. Y.), 6(1).
DesRuisseaux, L. A., Williams, V. J., McManus, A. J., Gupta, A. S., Carlyle, B. C., Azami, H., Gerber, J. A., Bolling, A. M., Cook, C. L., Betensky, R. A., & Arnold, S. E. (2020). A pilot protocol to assess the feasibility of a virtual multiple crossover, randomized controlled trial design using methylphenidate in mild cognitive impairment. Trials, 21(1), 1016.
Bryant, A. G., Hu, M., Carlyle, B. C., Arnold, S. E., Frosch, M. P., Das, S., Hyman, B. T., & Bennett, R. E. (2020). Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease. Frontiers in neurology, 11, 575953.
Katsumi, Y., Racine, A. M., Torrado-Carvajal, A., Loggia, M. L., Hooker, J. M., Greve, D. N., Hightower, B. G., Catana, C., Cavallari, M., Arnold, S. E., Fong, T. G., Vasunilashorn, S. M., Marcantonio, E. R., Schmitt, E. M., Xu, G., Libermann, T. A., Barrett, L. F., Inouye, S. K., Dickerson, B. C., Touroutoglou, A., … RISE Study Group (2020). The Role of Inflammation after Surgery for Elders (RISE) study: Examination of [11C]PBR28 binding and exploration of its link to post-operative delirium. NeuroImage. Clinical, 27, 102346.
Vallabh, S. M., Minikel, E. V., Williams, V. J., Carlyle, B. C., McManus, A. J., Wennick, C. D., Bolling, A., Trombetta, B. A., Urick, D., Nobuhara, C. K., Gerber, J., Duddy, H., Lachmann, I., Stehmann, C., Collins, S. J., Blennow, K., Zetterberg, H., & Arnold, S. E. (2020). Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease. BMC medicine, 18(1), 140.
Weinberg, M. S., Patrick, R. E., Schwab, N. A., Owoyemi, P., May, R., McManus, A. J., Gerber, J., Harper, D. G., Arnold, S. E., & Forester, B. (2020). Clinical Trials and Tribulations in the COVID-19 Era. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 28(9), 913–920.
Arnold S. E. (2020). "Senior Moments" or More? Diagnostic Evaluation of Cognitive Complaints in Older Adults and the Role of Cerebrospinal Fluid Biomarkers. The journal of applied laboratory medicine, 5(1), 219–224. 3
Vallabh, S. M., Nobuhara, C. K., Llorens, F., Zerr, I., Parchi, P., Capellari, S., Kuhn, E., Klickstein, J., Safar, J. G., Nery, F. C., Swoboda, K. J., Geschwind, M. D., Zetterberg, H., Arnold, S. E., Minikel, E. V., & Schreiber, S. L. (2019). Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development. Proceedings of the National Academy of Sciences of the United States of America, 116(16), 7793–7798.
Williams, V. J., Trombetta, B. A., Jafri, R. Z., Koenig, A. M., Wennick, C. D., Carlyle, B. C., Ekhlaspour, L., Ahima, R. S., Russell, S. J., Salat, D. H., & Arnold, S. E. (2019). Task-related fMRI BOLD response to hyperinsulinemia in healthy older adults. JCI insight, 5(14).
Koenig, A. M., Nobuhara, C. K., Williams, V. J., & Arnold, S. E. (2018). Biomarkers in Alzheimer's, Frontotemporal, Lewy Body, and Vascular Dementias. Focus (American Psychiatric Publishing), 16(2), 164–172.
Carlyle, B. C., Trombetta, B. A., & Arnold, S. E. (2018). Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias. Proteomes, 6(3), 32.
Arnold, S. E., & Betensky, R. A. (2018). Multicrossover Randomized Controlled Trial Designs in Alzheimer Disease. Annals of neurology, 84(2), 168–175.
Trombetta, B. A., Carlyle, B. C., Koenig, A. M., Shaw, L. M., Trojanowski, J. Q., Wolk, D. A., Locascio, J. J., & Arnold, S. E. (2018). The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease. PloS one, 13(3).
Arnold, S. E., Arvanitakis, Z., Macauley-Rambach, S. L., Koenig, A. M., Wang, H. Y., Ahima, R. S., Craft, S., Gandy, S., Buettner, C., Stoeckel, L. E., Holtzman, D. M., & Nathan, D. M. (2018). Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nature reviews. Neurology, 14(3), 168–181.
Koenig, A. M., Arnold, S. E., & Streim, J. E. (2016). Agitation and Irritability in Alzheimer's Disease: Evidenced-Based Treatments and the Black-Box Warning. Current psychiatry reports, 18(1), 3.